Slingshot members are tracking this event:

CymaBay's(CBAY) Seladelpar in Primary biliary cholangitis (PBC) Data from completed Phase 2 trial to be presented at DDW May 20, 2019

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
CBAY Community voting in process
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Seladelpar, Primary Biliary Cholangitis, Phase 2 Clinical Trial Data